论文部分内容阅读
冠状动脉粥样斑块破裂继发血栓出现,同时管腔闭塞是急性心肌梗死的主要原因,而早期开通梗死相关动脉是治疗AMI的关键。经皮冠脉介入治疗为目前治疗急性ST段抬高心肌梗死的首选方案[1]。替罗非班为GPⅡb/Ⅲa受体拮抗剂,近年在临床得到较为广泛的应用,本次研究对替罗非班不同给药方式的临床效果进行研究,现将结果比较如下:1资料与方法1.1一般资料选取南阳市中心医院2011年11
Coronary atherosclerotic plaque rupture secondary to thrombosis, and lumen occlusion is the main reason for acute myocardial infarction, and the early opening of infarct-related artery is the key to the treatment of AMI. Percutaneous coronary intervention for the treatment of acute ST-elevation myocardial infarction preferred program [1]. Tirofiban GPⅡb / Ⅲa receptor antagonists in recent years, has been widely used in clinical practice, this study on the clinical effects of different modes of administration of tirofiban study, the results are as follows: 1 Materials and Methods 1.1 General Information Select Nanyang Central Hospital 2011 11